Huace Film&TV:Expect more earnings from TV drama to be recognized in 2H17

类别:公司研究 机构:德意志银行 研究员:Tallan Zhou,Karen Tang 日期:2017-08-03

1H17core earnings down 8% yoy mainly due to margin decrease in TV drama

    Huace Film&TV announced its 1H17results. Although the company’s 2016topline increased by 13% yoy to RMB1,75bn, its core earnings (non-recurring itemsmainly include government subsidies) decreased by 8% yoy to RMB225m. Webelieve that this is mainly due to the significant margin decrease because someof the TV drama revenue/profit recognition will be delayed in 2H17. We maintainour Buy rating for Huace with a target price of RMB14.8.

    Top line up 13% yoy mainly driven by TV drama and talent agency business

    Total revenue increased 13% yoy to RMB1.75bn, which is attributable to: 1) theTV drama production top line increasing by 39% yoy to RMB1.44bn, and 2) thetalent agency top line increasing by 621% yoy to RMB46m. 1H17Chinese movies'weak performance has resulted in a 19% yoy drop in the company’s film businesstop line. The company also shift their film strategy to distribution instead ofproduction. In addition, we saw significant growth of its talent agency and onlinegaming business. However, since total gross margin decreased to 25% in 1H17from 34% in 1H16and SG&A expenses increased by 38% yoy in 1H17, core netearnings dropped by 8% yoy.

    We believe earnings will lean more on 2H17

    Since more revenue/profit will be recognized in 2H17, we are confident on our TVdrama revenue growth estimate of 20%. The company disclosed that there will bemore than 11TV drama's revenue recognition in 2H17. Looking at the full year of2017, management seems to be confident of delivering earnings of RMB 650m,as guided in its previous stock incentive plan.

股票代码 股票名称 最新价(元) 涨跌额(元) 涨跌幅(%) 成交额(万元) 成交量(手)
300133 @nn@ @n@ @c@ @cc@ @v@ @t@

数据推荐

投资评级

更多>>
股票名称最新评级目标价研报
海信家电 持有 -- 研报
盛达矿业 中性 -- 研报
飞科电器 中性 -- 研报
广联达 中性 -- 研报
万华化学 买入 53.00 研报
爱柯迪 买入 -- 研报
恒瑞医药 买入 -- 研报
华东医药 买入 -- 研报
丽珠集团 持有 -- 研报
爱尔眼科 买入 -- 研报
天坛生物 买入 -- 研报

盈利预测

评级选股>>
股票名称11年EPS12年EPS研报
海信家电 0.38 0.36 研报
盛达矿业 1.04 0.75 研报
飞科电器 0 0 研报
广联达 1.09 0.91 研报
万华化学 0.92 1.01 研报
丽珠集团 1.51 1.48 研报
华东医药 0.92 1.10 研报
恒瑞医药 0.88 0.88 研报
爱柯迪 0 0 研报
爱尔眼科 0.51 0.50 研报
天坛生物 0.46 0.52 研报

股票关注度

更多>>
股票名称关注度平均评级最新评级
贵州茅台 38 买入 买入
完美世界 34 持有 持有
保利地产 33 买入 持有
五粮液 31 买入 买入
比亚迪 31 持有 中性
伊利股份 30 持有 买入
完美世界 30 持有 持有
广联达 28 持有 中性
瀚蓝环境 27 持有 买入
通威股份 27 买入 买入
新宙邦 27 持有 买入
中信证券 26 持有 中性
上汽集团 26 买入 买入
万华化学 26 持有 买入
万科A 26 买入 买入
三一重工 25 持有 买入
瀚蓝环境 25 持有 买入

行业关注度

更多>>
行业名称关注度关注股票数买入评级数
电子信息 615 81 328
汽车制造 447 34 269
电子器件 412 53 236
钢铁行业 405 28 253
建筑建材 374 44 194
化工行业 367 46 159
金融行业 345 24 167
生物制药 314 57 161
房地产 271 25 197
机械行业 270 52 121
煤炭行业 259 28 111
食品行业 258 22 108
酿酒行业 237 17 124
家电行业 226 14 140
商业百货 197 32 105
酒店旅游 192 20 62
有色金属 187 38 61